Skip to main content

Holiday schedule

Quest Diagnostics Patient Service Centers will have modified hours during the holiday season.

  • Closing early at 12:00pm on December 24, 2025
  • Closed on December 25, 2025
  • Closing early at 12:00pm on December 31, 2025
  • Closed on January 1, 2026


Have a healthy, happy holiday!

Hide
Quest Diagnostics

Assessment of Urinary Buprenorphine, Norbuprenorphine and Naloxone Concentrations in Patients in Prescription Drug Monitoring Programs

SOFT 2020: Society of Forensic Toxicologists 
Virtual [in-person conference canceled], September 21-25, 2020

Assessment of urinary buprenorphine, norbuprenorphine and naloxone concentrations in patients in prescription drug monitoring programs

Authors: Solano R, Jenkins AJ

Specialties: Prescription drug monitoring, Toxicology

Related content

Audio Podcast
Dangerous Drug Combinations
Test FAQ
Drug Toxicology Monitoring Oral Fluid Testing
On-Demand Webinar
The Growing Crisis of Novel Psychoactive Substances
Test FAQ
Novel Psychoactive Substances (NPS) Panel
Audio Podcast
Presumptive vs Definitive Drug Testing: What You Need to Know

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.